Literature DB >> 1696881

Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system.

I Ocrant1, C T Fay, J T Parmelee.   

Abstract

Insulin-like growth factor binding proteins (IGFBP) are thought to modulate the biological actions of the insulin-like growth factors (IGF), including possible regulatory roles in the growth and differentiation of the central nervous system. Extracellular fluids usually contain a mixture of IGFBPs, three of which have been cloned, sequenced, and designated IGFBP-1, -2, and -3. We used Western ligand blotting, immunoprecipitation, and competitive binding analysis to characterize IGFBPs found in fetal and adult rat cerebrospinal fluid (CSF) and IGFBPs produced by cultures of neonatal rat choroid plexus, astrocytes, and C6 glial cells. Pooled rat CSF contains primarily IGFBP-2 (a narrow band at Mr = 29,000), lesser quantities of IGFBP-3 (a multicomponent broad band at Mr = 37,500-43,000), and trace amounts of low mol wt IGFBPs. Conditioned medium from cultures of choroid plexus cells contained a single binding protein corresponding to IGFBP-2, whereas C6 cells made predominately an IGFBP corresponding to IGFBP-3. Astrocytes secreted two IGFBPs corresponding to IGFBP-2 and -3, primarily IGFBP-3. Neonatal CSF contained substantially more binding activity corresponding to IGFBP-2 than did adult CSF. In all samples showing Western ligand binding profiles corresponding to IGFBP-2, identification was established by immunoprecipitation. Competitive binding analysis performed on choroid plexus IGFBP showed preferential high affinity binding for IGF-II compared with that for IGF-I. In conclusion, CSF contains a mixture of distinct IGFBPs, primarily IGFBP-2. The other IGFBPs found in CSF are capable of being synthesized locally within the central nervous system by glial cells and neurons, suggesting that they are not derived from plasma by transport across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696881     DOI: 10.1210/endo-127-3-1260

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

Authors:  S A Loddick; X J Liu; Z X Lu; C Liu; D P Behan; D C Chalmers; A C Foster; W W Vale; N Ling; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 3.  Generating new neurons to circumvent your fears: the role of IGF signaling.

Authors:  R C Agis-Balboa; A Fischer
Journal:  Cell Mol Life Sci       Date:  2013-03-30       Impact factor: 9.261

4.  Molecular characterization and expression pattern of insulin-like growth factor binding protein-3 (IGFBP-3) in common carp, Cyprinus carpio.

Authors:  Wenbo Chen; Haoran Lin; Wensheng Li
Journal:  Fish Physiol Biochem       Date:  2012-06-27       Impact factor: 2.794

5.  Cloning, gene regulation, and neuronal proliferation functions of novel N-terminal-truncated carboxypeptidase E/neurotrophic factor-αl variants in embryonic mouse brain.

Authors:  Lan Xiao; Xuyu Yang; Vinay Kumar Sharma; Y Peng Loh
Journal:  FASEB J       Date:  2018-07-31       Impact factor: 5.191

Review 6.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

7.  IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3.

Authors:  Janaina S de Souza; Cassiano Carromeu; Laila B Torres; Bruno H S Araujo; Fernanda R Cugola; Rui M B Maciel; Alysson R Muotri; Gisele Giannocco
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

Review 8.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampus.

Authors:  Jihui Zhang; Billie M Moats-Staats; Ping Ye; A Joseph D'Ercole
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

10.  Beta-adrenergic receptors mediate a stress-induced decrease in IGF-II mRNA in the rat cerebellum.

Authors:  N Tritos; E Kitraki; H Phillipidis; F Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  1998-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.